Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

What To Expect For Universal Health's (UHS) Q3 Earnings

Published 10/20/2019, 11:19 PM
Updated 07/09/2023, 06:31 AM
AAPL
-
COR
-
MOH
-
MD
-
UHS
-

Universal Health Services, Inc. (NYSE:UHS) is set to report third-quarter 2019 results on Oct 24 after market close.

The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is pegged at $2.28, suggesting a 2.2% rise from the year-ago reported figure.

In the last reported quarter, the company reported adjusted earnings of $2.76 per share, beating the Zacks Consensus Estimate by 10.8%. Moreover, the bottom line improved 11.7% year over year and this upside is mainly attributable to rising revenues.

Let’s see how things are shaping up for this announcement.

Universal Health’s overall performance is expected to have been fueled by both its Acute Care and Behavioral Health segments. The Zacks Consensus Estimate for net revenues at its Acute Care and Behavioral Health segments implies an upside of 5.8% and 5.5%, respectively, from the prior-year reported numbers.

The Zacks Consensus Estimate for total revenues in the third quarter stands at $2.8 billion, indicating 4.1 % growth from the year-earlier reported figure.
Licensed beds in both Acute Care hospitals and the Behavioral Health centers have been increasing since 2012. The same is likely to have continued in the third quarter of 2019 on the back of additional facilities.

The Zacks Consensus Estimate for average licensed beds at Behavioral Health Centers hints at a 2.3% rise from the year-ago reported number. Also, the Zacks Consensus Estimate for average licensed beds at Acute Care Hospitals in the United States and Puerto Rico indicates an increase of 2.6% from the prior-year reported figure.

The company’s overall growth is likely to have been driven by increased admissions at both its Acute Care hospitals and the Behavioral Health segments.

Continued share buybacks might have provided an additional impetus to the bottom line.

However, Universal Health is anticipated to have incurred escalating operating expenses due to higher salaries, wages and benefits plus other operating expenses, which could negatively impact third-quarter earnings.

Interest expenses of the company might have remained at elevated levels.

What the Quantitative Model States

Our proven model does not conclusively predict an earnings beat for Universal Health this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Earnings ESP: Universal Health has an Earnings ESP of 0.00%. This is because both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $2.28. You can see the complete list of today’s Zacks #1 Rank stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank: Universal Health carries a Zacks Rank #3, which increases the predictive power of ESP. However, the company’s 0.00% ESP makes surprise prediction difficult for the stock this time around.

Stocks to Consider

Some stocks worth considering from the medical sector with the perfect mix of elements to surpass estimates in the next releases are as follows:

Mednax, Inc (NYSE:MD) is set to report third-quarter earnings on Nov 1. The stock has a Zacks Rank of 3 and an Earnings ESP of +1.10%.

AmerisourceBergen Corporation (NYSE:ABC) is slated to announce third-quarter earnings on Nov 7. The stock has an Earnings ESP of +0.55% and is Zacks #3 Ranked.

Molina Healthcare, Inc (NYSE:MOH) is set to report third-quarter earnings on Oct 29. The stock has a Zacks Rank of 1 and an Earnings ESP of +0.92%.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Molina Healthcare, Inc (MOH): Free Stock Analysis Report

Mednax, Inc (MD): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Universal Health Services, Inc. (UHS): Free Stock Analysis Report

AmerisourceBergen Corporation (ABC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.